Pricing Log in Create free account

Immunocore Holdings PLC Sponsored ADR (IMCR) vs SELLAS Life Sciences Group, Inc. (SLS)

Immunocore Holdings PLC Sponsored ADR and SELLAS Life Sciences Group, Inc. are both Biotechnology companies. Immunocore Holdings PLC Sponsored ADR and SELLAS Life Sciences Group, Inc. are of similar size ($1.7B and $1.6B). SELLAS Life Sciences Group, Inc. has the higher net margin (0.00% vs −7.48%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Immunocore Holdings PLC Sponsored ADR leads on 8 and SELLAS Life Sciences Group, Inc. on 7.

Valuation

Metric IMCR SLS Biotechnology median
P/E n/m n/m 11.58
P/S 3.81 151.89 9.61
P/B 3.90 11.59 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales 2.74 138.74 9.43
Earnings yield (2.00%) (2.49%) (32.28%)
Free cash flow yield (1.11%) (2.41%) (22.27%)

Profitability

Metric IMCR SLS Biotechnology median
Gross margin 98.86% 0.00% 68.81%
Operating margin (6.76%) 0.00% 0.00%
Net margin (7.48%) 0.00% 0.00%
Free cash flow margin (4.24%) 0.00% 0.00%
Return on equity (7.87%) (39.63%) (50.30%)
Return on assets (2.88%) (36.54%) (45.47%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMCR SLS Biotechnology median
Revenue growth (TTM) 13.10% — 6.78%
EPS growth (last fiscal year) 30.39% 50.00% 29.88%
Revenue growth, 5-year CAGR 59.57% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMCR SLS Biotechnology median
Debt to equity 0.94 0.00 0.00
Current ratio 4.62 18.83 4.74
Net debt to EBITDA 11.19 2.54 1.01

Dividend

Metric IMCR SLS Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric IMCR SLS Biotechnology median
Market cap 1.63b 1.70b 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack